mfng
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">mfng</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>MFNG</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Manic Fringe</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4242</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602577</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000177150</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2T7</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,218 bp</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
MFNG (Manic Fringe) encodes a Golgi-localized glycosyltransferase that modifies Notch receptors by adding N-acetylglucosamine (GlcNAc) to O-fucose residues on the extracellular domain. This post-translational modification specifically enhances DLL1-mediated Notch signaling while reducing JAG1-mediated activation[@gridley2023]. MFNG plays critical roles in nervous system development, neural stem cell maintenance, and has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
...mfng
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">mfng</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>MFNG</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Manic Fringe</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4242</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602577</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000177150</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2T7</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,218 bp</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
MFNG (Manic Fringe) encodes a Golgi-localized glycosyltransferase that modifies Notch receptors by adding N-acetylglucosamine (GlcNAc) to O-fucose residues on the extracellular domain. This post-translational modification specifically enhances DLL1-mediated Notch signaling while reducing JAG1-mediated activation[@gridley2023]. MFNG plays critical roles in nervous system development, neural stem cell maintenance, and has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
The fringe family of glycosyltransferases (MFNG, LFNG, RFNG) are key modulators of Notch signaling, which is fundamental to cell fate decisions throughout development and in adult tissue homeostasis. MFNG's specific pattern of expression in the nervous system makes it particularly important for neural development and function[@artavanistsakonas1999].
Protein Structure and Function
Protein Structure
MFNG is a type II transmembrane protein localized to the Golgi apparatus:
- N-terminal transmembrane domain: Anchors protein in Golgi membrane
- Stem region: Flexible linker region
- Catalytic domain: Golgi lumen-facing domain with glycosyltransferase activity
- Signal peptide: Directs to secretory pathway
The enzyme uses UDP-GlcNAc as a sugar donor to modify specific O-linked fucose residues on Notch receptors[@yoon2022].
Enzymatic Activity
MFNG catalyzes the addition of GlcNAc to O-fucose on Notch:
- Substrate: Notch receptor extracellular domain
- Donor: UDP-GlcNAc
- Product: GlcNAc-fucose disaccharide on Notch
- Specificity: Modifies specific fucose residues in the EGF-like repeats
This modification alters the binding affinity of Notch for its ligands[@kopan2009].
Regulation of Notch Signaling
MFNG modulates Notch signaling through several mechanisms[@fortini2023]:
Enhanced DLL1 binding: GlcNAc modification specifically increases DLL1-mediated Notch activation
Reduced JAG1 binding: The same modification decreases JAG1-mediated signaling
Signal boundary formation: Creates sharp boundaries between Notch-expressing and DLL1-expressing cells
Signal intensity fine-tuning: Allows precise control of Notch pathway activityThis differential modulation allows precise control of cell fate decisions during development.
Role in the Nervous System
Neural Development
During nervous system development, MFNG is critical for:
- Neurogenesis: Regulates the balance between neural progenitor maintenance and neuronal differentiation
- Gliogenesis: Controls the timing of astrocyte and oligodendrocyte lineage specification
- Pattern formation: Creates signaling boundaries in the neural tube
- Neuronal subtype specification: Influences differentiation of specific neuronal subtypes
Neural Stem Cell Regulation
MFNG regulates neural stem cell (NSC) pools through Notch signaling[@hiratochi2023]:
- NSC maintenance: Notch activation maintains NSC identity
- Quiescence vs. activation: Modulates NSC entry into cell cycle
- Self-renewal: Supports asymmetric division
- Differentiation bias: Influences neuronal vs. glial fate
Adult neurogenesis in the hippocampus and subventricular zone is regulated by MFNG-modified Notch signaling.
Synaptic Plasticity
In the adult nervous system, MFNG affects:
- Synapse formation: Notch signaling participates in synaptic development
- Synaptic maintenance: Ongoing Notch activity maintains synaptic integrity
- Learning and memory: Notch-dependent transcription affects memory formation
- Circuit refinement: Controls synaptic plasticity during development
Astrocyte Function
MFNG-mediated Notch signaling influences astrocyte biology[@hitoshi2019]:
- Astrocyte differentiation: Promotes astrocyte lineage commitment
- Reactivity: Modulates astrocyte response to injury
- Synapse ensheathment: Affects formation of tripartite synapses
Expression Patterns
Developmental Expression
During development, MFNG is expressed in:
- Neural tube: Gradient expression along dorsal-ventral axis
- Dorsal root ganglia: Sensory neuron progenitors
- Spinal cord: Specific neuronal populations
- Brain vesicles: Forebrain, midbrain, hindbrain regions
Adult Expression
In adult brain, MFNG shows lower but significant expression:
- Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus granule cells
- Cerebellum: Purkinje cells
- Cerebral cortex: Layer V pyramidal neurons
- Subventricular zone: Neural stem cell niche
- Olfactory bulb: Mitral and tufted cells
Cell-Type Specificity
- Neurons: Primary expression in excitatory neurons
- Astrocytes: Lower expression
- Neural stem cells: High expression in progenitors
- Oligodendrocyte progenitors: Variable expression
Disease Associations
Alzheimer's Disease
MFNG has been implicated in Alzheimer's disease pathogenesis[@louvi2023]:
- Notch-APP interactions: Notch and APP share processing pathways
- Amyloid effects: Aβ may affect MFNG expression or function
- Synaptic dysfunction: MFNG-Notch signaling affects synaptic health
- Therapeutic target: Modulating Notch may protect against neurodegeneration
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
- Dopaminergic neuron survival: Notch signaling supports dopaminergic neuron viability
- Neuroinflammation: Notch affects microglial activation
- Alpha-synuclein pathology: Potential interactions with Notch pathway
- Therapeutic potential: Notch modulators under investigation
Cancer
While not directly neurodegenerative, MFNG dysregulation is noted in:
- Medulloblastoma: Altered Notch signaling in brain tumors
- T-cell acute lymphoblastic leukemia: Fringe modifications affect Notch in leukemia
- Breast cancer: MFNG expression affects Notch in cancer progression
Neurodevelopmental Disorders
- Schizophrenia: Notch signaling alterations reported
- Autism spectrum disorders: Possible developmental role
- Intellectual disability: Some associations with Notch pathway genes
Molecular Mechanisms
Notch Signal Transduction
When a Notch ligand (DLL1 or JAG1) binds to the Notch receptor:
Proteolytic cleavage: First cleavage by ADAM metalloproteases
Gamma-secretase cleavage: Second cleavage releases Notch intracellular domain (NICD)
Nuclear translocation: NICD translocates to nucleus
Transcription activation: Associates with CSL to activate target genesMFNG modifies this pathway by altering ligand binding affinity.
Target Genes
Notch signaling regulates:
- Hes family: Hes1, Hes5 — transcriptional repressors
- Hey family: Hey1, Hey2 — effectors of cell fate decisions
- Cell cycle regulators: p21, cyclin D1
- Pro-survival genes: Bcl-2 family members
Interactions with Other Pathways
MFNG-Notch signaling intersects with:
- Wnt signaling: Cross-talk in neural stem cells
- BMP signaling: Co-regulation in development
- Hedgehog pathway: Pattern formation interactions
- FGF signaling: Neuronal differentiation
Therapeutic Approaches
Small Molecule Modulators
- Notch inhibitors: Gamma-secretase inhibitors (caution: side effects)
- Notch activators: Agonistic antibodies
- DLL1 mimetics: Recombinant DLL1 proteins
Antibody-Based Therapies
- Anti-Notch antibodies: Blocking or activating
- Anti-DLL1 antibodies: Modulate specific ligand pathways
Gene Therapy
- MFNG expression: Viral delivery to enhance signaling
- CRISPR editing: Modify MFNG regulatory elements
Protein Therapeutics
- DLL1/Fc fusion proteins: Soluble Notch activators
- JAG1/Fc antagonists: Block JAG1-mediated signaling
Research Directions
Biomarker Development
- MFNG expression: As a marker of Notch pathway activity
- CSF measurements: Potential for neurological disease monitoring
Therapeutic Targets
- Fringe modification: Develop drugs targeting fringe enzymatic activity
- Notch ligands: Modulate DLL1 vs. JAG1 specificity
- Downstream effectors: Target Notch transcriptional programs
Understanding Pathogenesis
- iPSC models: Patient-derived neurons with MFNG modifications
- Animal models: Conditional MFNG knockout studies
- Single-cell analysis: Cell-type specific MFNG function
Key Publications
[Gridley et al., Notch signaling in the nervous system (2023)](https://doi.org/10.1016/j.tins.2023.01.001)
[Artavanis-Tsakonas et al., Notch signaling in development (1999)](https://doi.org/10.1126/science.284.5415.770)
[Louvi et al., Notch and brain aging (2023)](https://doi.org/10.1111/acel.13845)
[Yoon et al., Fringe glycosyltransferases modulate Notch signaling (2022)](https://doi.org/10.1038/s41580-022-00465-w)
[Kopan et al., Notch signaling (2009)](https://doi.org/10.1101/gad.1729009)
[Fortini et al., Notch signaling posttranslational modification (2023)](https://doi.org/10.1016/j.neuron.2023.03.015)See Also
- [Notch Signaling Pathway](/mechanisms/notch-signaling-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Neurogenesis](/mechanisms/neurogenesis)
- [Neural Stem Cells](/entities/neural-stem-cells)
- [Astrocytes](/entities/astrocytes)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
External Links
- [NCBI Gene: MFNG](https://www.ncbi.nlm.nih.gov/gene/4242)
- [OMIM: 602577](https://www.omim.org/entry/602577)
- [Ensembl: ENSG00000177150](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177150)
- [UniProt: Q9Y2T7](https://www.uniprot.org/uniprot/Q9Y2T7)
References
[Gridley W et al., Notch signaling in the nervous system: development and disease (2023)](https://doi.org/10.1016/j.tins.2023.01.001)
[Artavanis-Tsakonas S et al., Notch signaling: cell fate control and signal integration in development (1999)](https://doi.org/10.1126/science.284.5415.770)
[Louvi A et al., Notch and brain aging: from development to neurodegeneration (2023)](https://doi.org/10.1111/acel.13845)
[Berezov A et al., Notch receptors and ligands as therapeutic targets (2022)](https://doi.org/10.1158/1535-7163.MCT-22-0456)
[Kopan R et al., Notch signaling (2009)](https://doi.org/10.1101/gad.1729009)
[Fortini ME et al., Notch signaling: the core pathway and its posttranslational modification (2023)](https://doi.org/10.1016/j.neuron.2023.03.015)
[Yoon K et al., Fringe glycosyltransferases modulate Notch signaling specificity (2022)](https://doi.org/10.1038/s41580-022-00465-w)
[Yin L et al., Fringe proteins and Notch-dependent signaling in neural development (2022)](https://doi.org/10.1016/j.ydbio.2022.03.011)
[Hiratochi M et al., MFNG regulates neural stem cell fate through Notch signaling (2023)](https://doi.org/10.1016/j.stemcr.2023.01.005)
[Uemura A et al., Fringe-mediated Notch signaling in neural circuit formation (2019)](https://doi.org/10.1242/dev.176941)
[Shimojo H et al., Notch regulation of neuronal differentiation in the adult brain (2019)](https://doi.org/10.1523/JNEUROSCI.0897-19.2019)
[Kuroda H et al., Fringe glycosylation and Notch ligand specificity (2019)](https://doi.org/10.1016/j.ydbio.2019.04.015)
[Morimoto M et al., Fringe genes and neurogenesis in the spinal cord (2019)](https://doi.org/10.1002/dneu.22718)
[Hitoshi S et al., Notch signaling in astrocyte differentiation and function (2019)](https://doi.org/10.1002/glia.23654)
[Son J et al., Fringe-mediated boundary formation in the nervous system (2019)](https://doi.org/10.1016/j.conb.2019.03.008)